Edition:
India

Xenetic Biosciences Inc (XBIO.OQ)

XBIO.OQ on NASDAQ Stock Exchange Capital Market

2.19USD
18 Mar 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.19
Open
$2.25
Day's High
$2.25
Day's Low
$2.14
Volume
4,223
Avg. Vol
10,884
52-wk High
$8.94
52-wk Low
$1.45

Chart for

About

Xenetic Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on discovery, research and development of biologic drugs and novel oncology therapeutics. The Company’s lead investigational product candidate is oncology therapeutic XBIO-101, which is used for the treatment of progestin - resistant... (more)
No analyst recommendations are available for .

Overall

Beta: 1.30
Market Cap(Mil.): $25.89
Shares Outstanding(Mil.): 8.72
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates